Sustainability & Climate

Director Valerio Zanoli's new documentary doesn't just raise awareness; its profits build homes, challenging how we fight the global housing crisis.

Intellia Therapeutics prepares for a critical March, where it will outline its gene editing future to investors amid safety questions and market pressures.

As tax fraud spikes, Allstate unveils an industry-first plan to give victims their stolen refund money upfront, tackling a growing financial nightmare.

Dr. Frank Smith joins XenoSTART to lead its preclinical unit, aiming to leverage its vast patient-derived model library to speed up oncology drug development.

With 80% of Indian diets lacking protein, the fast-food giant is serving up a science-backed solution. But can a burger truly bridge a national nutrition gap?

Facing SEC delays, Aptose Biosciences secures an $11.1M lifeline from its acquirer, Hanmi, highlighting financial strain as the critical deal moves forward.

The bioprocessing leader posted robust 2025 earnings, outperforming the market with strategic innovation and a major expansion into Asian markets.

Cullinan Therapeutics heads to key investor conferences, ready to showcase its T-cell engager platform for both cancer and challenging autoimmune diseases.

With no approved therapies for Hepatitis E, Atea Pharmaceuticals' new drug shows potent preclinical results, offering a potential lifeline for vulnerable patients.

Cell and gene therapy manufacturer OXB posts a dramatic turnaround to profitability, with surging revenues and an ambitious forecast for the coming years.

Life Time posts record 2025 earnings and a 230% Q4 profit surge, announcing a $500M share buyback and an aggressive expansion of its 'athletic country clubs'.

Drilling at the Tesorito deposit has intersected a potential high-grade feeder zone, suggesting a much larger and richer system than previously modeled.

Forvia reports a €2.1B net loss but shows improved operations and cash flow. Is this strategic pain a necessary step toward long-term gain?

South Korean food giant Daesang signals a major expansion in Japan after a smash debut at a top trade show, targeting the growing taste for authentic kimchi.

With key conferences ahead, Supernus Pharmaceuticals must prove its strategy can deliver growth in the competitive central nervous system drug landscape.

A new partnership brings an FDA-designated breakthrough device to more patients, fueled by a key Medicare payment that could reshape the trauma market.

The cannabis giant upsizes its credit facility by CAD $15M, signaling strong lender confidence and fueling its ambitious global expansion plans.

A new partnership brings hyper-local weather AI to snow removal, promising fewer slip-and-falls, smarter salt use, and ironclad liability protection.

As Mueller Water Products heads to a key industry symposium, a new CEO and record earnings set the stage for its vision for America's water future.

A new JBF report reveals how independent restaurants are battling costs, tech, and expectations with surprising optimism and strategic shifts.